What does ST‑segment elevation in leads V4‑V6 indicate and how should it be managed?

ST-Segment Elevation in Leads V4-V6: Diagnosis and Management

ST-segment elevation in leads V4-V6 indicates acute myocardial infarction involving the anterolateral wall of the left ventricle, requiring immediate reperfusion therapy with primary percutaneous coronary intervention (PCI) as the preferred strategy, or fibrinolytic therapy if PCI cannot be performed within 120 minutes of diagnosis. 1

Clinical Significance and Anatomical Correlation

ST-segment elevation in V4-V6 localizes to the anterolateral myocardial territory, typically resulting from occlusion of the left anterior descending (LAD) coronary artery, particularly when the occlusion is distal to the first septal and diagonal branches. 1 The spatial vector of ST-segment elevation directed laterally indicates involvement of the lateral wall in addition to anterior structures. 1

• When ST elevation appears in V4-V6 without elevation in V1-V2, this suggests more distal LAD occlusion below the first septal and diagonal branches, sparing the basal interventricular septum. 1
• The presence of ST elevation extending to V4-V6 correlates with larger areas of myocardium at risk and greater myocardial injury, particularly when these changes occur in the context of inferior STEMI. 2, 3
• In inferior STEMI patients, ST elevation >2 mm in V5-V6 predicts mega-artery occlusion and impaired myocardial reperfusion (myocardial blush grade 0-1), indicating worse prognosis. 3

Immediate Management Algorithm

Step 1: Confirm STEMI Diagnosis

• Verify persistent ST-segment elevation with symptoms of ischemia <12 hours duration. 1
• Measure ST elevation at the J-point: threshold for abnormal elevation in V4-V6 is >0.1 mV (1 mm) in adults. 1

Step 2: Initiate Immediate Medical Therapy

Administer aspirin and antiplatelet therapy immediately:

• Aspirin 300 mg oral or IV (if unable to swallow) as soon as possible. 1
• Potent P2Y12 inhibitor: prasugrel or ticagrelor preferred over clopidogrel, given before or at the time of PCI. 1
• Anticoagulation: unfractionated heparin as weight-adjusted IV bolus (enoxaparin or bivalirudin are alternatives). 1

Step 3: Determine Reperfusion Strategy Based on Time

Primary PCI Strategy (Preferred):

• Reperfusion therapy is mandatory in all patients with symptoms <12 hours and persistent ST elevation. 1
• Transfer directly to catheterization laboratory, bypassing emergency department. 1
• Primary PCI-capable centers must deliver 24/7 service without delay. 1

Fibrinolytic Therapy (If PCI Unavailable):

• Initiate if anticipated time from STEMI diagnosis to PCI >120 minutes. 1
• Administer within 10 minutes of STEMI diagnosis, preferably pre-hospital. 1
• Use fibrin-specific agents: tenecteplase, alteplase, or reteplase. 1
• Add clopidogrel plus aspirin for fibrinolysis patients. 1
• Use enoxaparin IV followed by subcutaneous (preferred over unfractionated heparin) until revascularization or up to 8 days. 1

Step 4: Post-Fibrinolysis Management (If Applicable)

All patients receiving fibrinolysis require transfer to PCI-capable center:

• Immediate transfer after fibrinolytic administration. 1
• Emergency angiography and rescue PCI immediately if fibrinolysis fails (<50% ST-segment resolution at 60-90 minutes) or hemodynamic/electrical instability develops. 1
• Routine angiography between 2-24 hours after successful fibrinolysis. 1

Critical Pitfalls to Avoid

Do not delay reperfusion for risk stratification or additional testing. The clock starts at STEMI diagnosis (ECG interpretation), not hospital arrival. 1

Avoid intravenous beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia. 1

Do not use fondaparinux for primary PCI. 1

Do not perform routine PCI of occluded infarct-related artery >48 hours after STEMI onset in asymptomatic patients. 1

Post-Acute Management

Dual antiplatelet therapy (DAPT) for 12 months:

• Aspirin 75-100 mg daily plus ticagrelor or prasugrel (or clopidogrel if others contraindicated). 1
• Add proton pump inhibitor in patients at high gastrointestinal bleeding risk. 1

Additional therapies:

• High-intensity statin started as early as possible and maintained long-term, targeting LDL-C <1.8 mmol/L (70 mg/dL). 1
• ACE inhibitors within 24 hours in patients with heart failure, LV dysfunction (LVEF <40%), diabetes, or anterior infarct. 1
• Beta-blockers in patients with heart failure and/or LVEF <40%. 1
• Routine echocardiography during hospitalization to assess LV/RV function, detect mechanical complications, and exclude LV thrombus. 1

Cardiac rehabilitation participation is mandatory for all patients. 1